Thank you Ran , thoroughly enjoyed that , the slides have more detail than the audio vocab , wish Richard Mollard had been allocated more time , great presentation and a brief overview of the previous Human Trial. 28 day, 4 patients showing Stable or Reduction in cancers plus they had already failed all current standard of care.
25 dogs in Phase I Efficacy and Palatability Trial ,, I actually thought it was only 16 so encouraged to understand that trial was larger than thought.
Also reinforces that Elanco have been closely involved with the Trial Perimeters. That's do they know exactly what they are getting.....
Pitt St Research Presentation by Dr Richard Mollard 28/11/2019, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $194.1K | 889.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4996 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 114999 | 4 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |